Centrum Medyczne Oporow
- Address
- lock Available on a paid plan
Inflammatory Bowel Disease Research
The gastroenterology unit at Centrum Medyczne Oporow pursues innovative therapies for chronic intestinal inflammation, aiming to improve long‑term remission and mucosal healing.
- Crohn's disease
- Ulcerative colitis
- Fistulizing perianal disease
- Pediatric IBD
- Combination biologic strategies
With 64 active trials and a team of 27 investigators, the site advances treatment options for patients across Poland.
Psoriasis & Psoriatic Arthritis
Research targets skin and joint manifestations of psoriatic disease, evaluating new biologics to reduce symptoms and prevent joint damage.
- Moderate to severe plaque psoriasis
- Active axial spondyloarthritis
- Peripheral psoriatic arthritis
- Skin‑joint comorbidity studies
- Weight‑adjusted dosing investigations
The program integrates dermatology and rheumatology expertise to deliver comprehensive care.
Autoimmune & Systemic Conditions
The center explores mechanisms of immune-mediated diseases beyond the gut, seeking therapies that modulate disease activity and improve quality of life.
- Rheumatoid arthritis
- Sjogren's syndrome
- Systemic sclerosis with lung involvement
- Musculoskeletal inflammation
- Immune phenotyping research
Collaborations with immunology laboratories support biomarker discovery and personalized treatment approaches.
Neurology & Movement Research
Trials address central nervous system disorders such as migraine and Tourette's disorder, focusing on symptom reduction and functional improvement.
- Acute migraine treatment
- Preventive migraine strategies
- Tourette's disorder pharmacotherapy
- Neuroinflammatory biomarkers
- Pediatric neurology safety studies
These studies complement the gastroenterology focus by investigating systemic inflammatory pathways affecting the brain.
Respiratory, ENT & Upper GI Studies
Investigations target upper airway and digestive tract conditions, including chronic rhinosinusitis and erosive esophagitis, to refine therapeutic options.
- Nasal polyps management
- Non‑polyp sinus disease
- GERD with erosive esophagitis
- Novel acid‑suppression agents
- Quality‑of‑life outcomes
The multidisciplinary team collaborates with otolaryngology and pulmonology specialists to broaden patient access to cutting‑edge care.
Metabolic & Renal Research
The department evaluates metabolic disorders that intersect with gastrointestinal health, aiming to mitigate complications of type 2 diabetes and chronic kidney disease.
- Diabetes‑related kidney outcomes
- Albumin‑to‑creatinine ratio reduction
- Obesity management in IBD
- Metabolic syndrome screening
- Long‑term safety of renal‑protective agents
Integrating endocrinology insights, the site supports holistic management of patients with overlapping metabolic and gastrointestinal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 12 therapeutic areas and 15 of 64 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 61 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 19 by active trials.
- 1Janssen Cilag International8active
lock +18 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International18trials
lock +20 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Oporow
lock Showing 1 of 85 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus Erythematosus | Bristol Myers Squibb International Corporation | Phase II | Not Recruiting | May 2019 | Mar 2025 |
IMP list
lock Showing 1 of 64 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Guselkumab | 8 | Unknown | 2022-11-22 | 2026-05-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.